262
Views
8
CrossRef citations to date
0
Altmetric
Non-Malignant Hematology

Encephaloduroarteriosynangiosis (EDAS) in young patients with cerebrovascular complications of sickle cell disease: Single-institution experience

, , , , , & show all
Pages 100-106 | Received 12 Oct 2016, Accepted 30 Jan 2017, Published online: 22 May 2017

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jennifer Light, Maria Boucher, Jacquelyn Baskin-Miller & Mike Winstead. (2023) Managing the Cerebrovascular Complications of Sickle Cell Disease: Current Perspectives. Journal of Blood Medicine 14, pages 279-293.
Read now

Articles from other publishers (7)

Philipp R Aldana, Ricardo A Hanel, Joseph Piatt, Sabrina H Han, Manisha M Bansal, Corinna Schultz, Cynthia Gauger, John M Pederson, John C Wellons III, Monica L Hulbert, Lori C Jordan, Adnan Qureshi, Kelsey Garrity, Adam P Robert, Asmaa Hatem, Jennifer Stein, Emily Beydler, P. David Adelson, Stephanie Greene, Paul Grabb, James Johnston, Shih‐Shan Lang, Jeffrey Leonard, Suresh N Magge, Alex Scott, Sanjay Shah, Edward R Smith, Jodi Smith, Jennifer Strahle, Sudhakar Vadivelu, Jennifer Webb & David Wrubel. (2023) Cerebral revascularization surgery reduces cerebrovascular events in children with sickle cell disease and moyamoya syndrome: Results of the stroke in sickle cell revascularization surgery retrospective study. Pediatric Blood & Cancer 70:7.
Crossref
Keng Siang Lee, John J. Y. Zhang, Sanjay Bhate, Vijeya Ganesan, Dominic Thompson, Greg James & Adikarige Haritha Dulanka Silva. (2023) Surgical revascularizations for pediatric moyamoya: a systematic review, meta-analysis, and meta-regression analysis. Child's Nervous System 39:5, pages 1225-1243.
Crossref
James Feghali, Risheng Xu, Wuyang Yang, Jason Anthony Liew, Jaishri Blakeley, Edward S. Ahn, Rafael J. Tamargo & Judy Huang. (2020) Moyamoya disease versus moyamoya syndrome: comparison of presentation and outcome in 338 hemispheres. Journal of Neurosurgery 133:5, pages 1441-1449.
Crossref
Danielle Terrell, Amey R. Savardekar, Stephen Garrett Whipple, Rimal H. Dossani, Robert F. Spetzler & Hai Sun. (2020) Cerebral Revascularization for Moyamoya Syndrome Associated with Sickle Cell Disease: A Systematic Review of the Literature on the Role of Extracranial-Intracranial Bypass in Treating Neurologic Manifestations of Pediatric Patients with Sickle Cell Disease. World Neurosurgery 137, pages 62-70.
Crossref
M. R. DeBaun, L. C. Jordan, A. A. King, J. SchatzE. VichinskyC. K. Fox, R. C. McKinstryP. TelferM. A. KrautL. DarazF. J. Kirkham & M. H. Murad. (2020) American Society of Hematology 2020 guidelines for sickle cell disease: prevention, diagnosis, and treatment of cerebrovascular disease in children and adults. Blood Advances 4:8, pages 1554-1588.
Crossref
Pedro Aguilar-Salinas, Kelsey Hayward, Roberta Santos, Vibhuti Agarwal, Eric Sauvageau, Ricardo A. Hanel & Philipp R. Aldana. (2019) Surgical Revascularization for Pediatric Patients with Sickle Cell Disease and Moyamoya Disease in the Prevention of Ischemic Strokes: A Single-Center Case Series and a Systematic Review. World Neurosurgery 123, pages 435-442.e8.
Crossref
Kristin P. Guilliams, Melanie E. Fields & Michael M. Dowling. (2019) Advances in Understanding Ischemic Stroke Physiology and the Impact of Vasculopathy in Children With Sickle Cell Disease. Stroke 50:2, pages 266-273.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.